Information Provided By:
Fly News Breaks for February 11, 2016
MDSO
Feb 11, 2016 | 05:59 EDT
JPMorgan analyst Sterling Auty says Medidata Solutions' Q4 revenue does not reflect the company's bookings strength. Medidata's bookings momentum "appears robust," but the timing of some large deals caused a miss relative to Q4 revenue expectations, Auty tells investors in a post-earnings research note. He lowered his price target for the shares to $52 from $60 and keeps an Overweight rating on the name.
News For MDSO From the Last 2 Days
There are no results for your query MDSO